While there is no evidence that IL-6 receptor-independent pathways lead to the increase of other inflammatory cytokines and bone destruction, it is possible that excessive serum IL-6 - as observed in inflammatory conditions more severe than RA - could secondarily induce pro-inflammatory cytokines that promote bone destruction. Here, IL6 is linked to rheumatoid arthritis.